Lilly Marketed Zyprexa For Dementia, Knowing It Didn’t Work For Dementia
Bloomberg has been doing a fine job with the recently released round of Zyprexa documents and the news just keeps getting more disgusting: Eli Lilly openly and illegally marketed Zyprexa off-label for dementia while the company knew from its own studies that the antipsychotic did nothing to address behavioral issues in the elderly and while knowing that its drug was killing elderly people. Lilly has already settled allegations around all of that with the feds and 30-plus states and pleaded guilty to a criminal misdemeanor in January over its marketing of the drug for use in the elderly, where the company did not have FDA approval, so these new documents simply flesh out corrupt behavior–I don’t know what else to call it–on Lilly’s part. Read the above-linked article for details.
I’m attempting to get my hands on the documents that Bloomberg has but so far the lawyers handling this case haven’t made up their minds as to whether they will release them. I’m not sure why they are playing favorites with Bloomberg, but that’s how it goes sometimes.
Related posts:
Posted in Furious Seasons